Search results
Results From The WOW.Com Content Network
Dengue fever is a mosquito-borne disease caused by dengue virus, prevalent in tropical and subtropical areas. It is frequently asymptomatic ; if symptoms appear, they typically begin 3 to 14 days after infection.
President Benigno Aquino III at the launching of the dengue vaccine school-based immunization program. In April 2016, the DOH launched the dengue vaccination campaign in Central Luzon, Calabarzon and Metro Manila, where about 700,000 individuals received at least one dose of the vaccine. [11] The government paid P3.5-billion for the vaccine. [10]
Dengue virus (DENV) is the cause of dengue fever.It is a mosquito-borne, single positive-stranded RNA virus of the family Flaviviridae; genus Flavivirus. [1] [2] Four serotypes of the virus have been found, and a reported fifth has yet to be confirmed, [3] [4] [5] all of which can cause the full spectrum of disease. [1]
In women where the pregnancy is not the first, malaria infection is more often asymptomatic, even at high parasite loads, compared to women having their first pregnancy. [1] There is a decreasing susceptibility to malaria with increasing parity, probably due to immunity to pregnancy-specific antigens. [1] Young maternal age and increases the ...
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]
Dengue fever (UK: / ˈ d ɛ ŋ ɡ eɪ / or US: / ˈ d ɛ ŋ ɡ iː /), also known as breakbone fever, is an infectious tropical disease caused by the dengue virus. Symptoms include fever , headache , myalgias and arthralgias , and a characteristic skin rash that is similar to measles .
Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. [1] Symptoms typically begin three to fourteen days after infection. [2] This may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin rash.
The plaque reduction neutralization test is used to quantify the titer of neutralizing antibody for a virus. [1] [2]The serum sample or solution of antibody to be tested is diluted and mixed with a viral suspension.